Innovation

Alzheimer’s Disease

Biogen’s New Alzheimer’s Drug Is “Hugely Important,” “One of the Biggest Moments” in 20 Years

Opinion

A Science Editor’s Love Letter to Hope

COVID-19 Testing

Meet the Team behind BU’s COVID-19 Testing Lab

CORONAVIRUS RESEARCH

In Deadly COVID-19 Lung Inflammation, BU Researchers Discover a Culprit in NFkB Pathway

CORONAVIRUS RESEARCH

What Sets Off Deadly Levels of Lung Inflammation in Some COVID-19 Patients?

Vaccine Race

Does Russia Really Have an Effective Coronavirus Vaccine?

Research Recovery

Amidst a Pandemic, State-of-the-Art Research Center Gets Reconfigured

COVID Testing

Robots, Nanobeads, and Data Modeling—The Science behind BU’s Coronavirus Testing Plan

Climate Action

Joe Biden’s $2 Trillion Climate Plan? BU Scientists Weigh In

CAREER PLANNING

Postdoc Academy Launches Remote Professional Development Course

Coronavirus

Tiny, Decoy “Sponges” Attract Coronavirus Away from Lung Cells

Translation

Translational Research Hub at BU Gets $38.3 Million Renewal from NIH

Return to Campus Labs

BU Unveils First Phase of Campuswide Research Recovery Plan

Alzheimer’s and AI

Deep Learning Algorithm Outperforms Experts in Making Alzheimer’s Diagnosis

Lowtech Lifesaver

For COVID-19 Patients, Could Breathing Easier Be as Simple as Flipping Over?

Biosensing

Mining Bacteria Parts to Build Around-the-Clock Biosensors

COVID-19 Testing

Facing Dire Shortages, 50 Boston Collaborators Develop Their Own FDA-Approved Coronavirus Test

Coronavirus Outbreak

BU NEIDL Scientists Join International Coronavirus Research Effort

Career Development

Alison Gammie Wants to Help BU’s Postdocs and Junior Faculty Map Out Their Career Paths

Research that Rocks

12 Breakthroughs That Wowed Us in 2019